Literature DB >> 7132568

Altered platelet serotonin uptake kinetics in schizophrenia and depression.

R D Kaplan, J J Mann.   

Abstract

Platelet uptake of serotonin (5-HT) was studied in drug-free groups of normal controls, depressives and schizophrenics. The Michaelis constant was significantly higher in both the schizophrenics and the depressives than in the controls. The Vmax did not differ significantly between the three groups. Uptake velocity at low substrate concentrations was significantly lower in the schizophrenic group and showed a similar trend in the depressives. There were no significant differences in Km or Vmax when depressives wee subclassified as unipolar and bipolar. There were no significant correlations between 5-HT uptake kinetics and severity of illness. These findings raise the possibility of a structural defect inthe 5-HT reuptake system in the major psychoses that reduces the affinity of the carrier for the amine. This alteration, if present in central serotonergic neurons, may play a role in the etiology and pathogenesis of depression and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7132568     DOI: 10.1016/0024-3205(82)90488-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders.

Authors:  A R Belous; S Ramamoorthy; R D Blakely; M I Factor; A M Dupin; A B Katasonov; R H Lozier; A G Beniashvili; M A Morozova; O S Brusov
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

Review 2.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Serotonin transport kinetics correlated between human platelets and brain synaptosomes.

Authors:  Jeffrey L Rausch; Maria E Johnson; Junqing Li; Julian Hutcheson; Benjamin M Carr; Katina M Corley; Amanda B Gowans; Joseph Smith
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

4.  Predicting factors for absenteeism in patients with major depressive disorders.

Authors:  E Souêtre; H Lozet; I Cimarosti
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

5.  Altered serotonin uptake kinetics in multiple sclerosis.

Authors:  M Markianos; C Sfagos
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

Review 6.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders.

Authors:  Hridya Jayamohananan; Maneesha Kalappurackal Manoj Kumar; Aneesh T P
Journal:  Adv Pharm Bull       Date:  2019-08-01

Review 8.  Conductive Nanodiamond-Based Detection of Neurotransmitters: One Decade, Few Sensors.

Authors:  Saheed E Elugoke; Omolola E Fayemi; Abolanle S Adekunle; Thabo T I Nkambule; Bhekie B Mamba; Eno E Ebenso
Journal:  ACS Omega       Date:  2021-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.